Vortioxetine

CAS No. 508233-74-7

Vortioxetine ( —— )

Catalog No. M14740 CAS No. 508233-74-7

Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 39 Get Quote
25MG 57 Get Quote
50MG 78 Get Quote
100MG 113 Get Quote
200MG 203 Get Quote
500MG 332 Get Quote
1G 478 Get Quote

Biological Information

  • Product Name
    Vortioxetine
  • Note
    Research use only, not for human use.
  • Brief Description
    Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
  • Description
    Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT1A; 5-HT1B; 5-HT3A; 5-HT7; SERT
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    508233-74-7
  • Formula Weight
    298.45
  • Molecular Formula
    C18H22N2S
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO, Ethanol: 200 mM
  • SMILES
    CC1=CC(C)=C(SC2=CC=CC=C2N2CCNCC2)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bang-Andersen B, et al. J Med Chem, 2011, 54(9), 3206-322
molnova catalog
related products
  • Urapidil

    Urapidil is a sympatholytic antihypertensive drug. It acts as an α1-adrenoceptor antagonist and as an 5-HT1A receptor agonist.

  • Minaprine dihydrochl...

    Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states.

  • Lerisetron

    Lerisetron is an antagonist of serotonin type 3 (5-HT3) receptor, with antiemetic activity.